FDA 483 - Chase Medical - February 25, 2021

An FDA inspection of KDL Medical Inc dba Chase Medical, a device manufacturer in Richardson, TX, identified two significant observations. The firm failed to adequately validate the sterilization process for a Class I Sternal Retractor device. Additionally, the company did not implement proper statistical techniques, specifically failing to follow its established sampling plan for receiving inspection of components.